Physician profile
Monica Chacon
NPI 1922112697
$1,658.13
in general payments reported to CMS, 2019-2025
23 companies · $45.90 in 2025
The $45.90 reported for 2025 was less than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $984 · 2020: $78.77 · 2021: $231 · 2023: $108 · 2024: $210 · 2025: $45.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $317.94 | 2019-2025 | Briviact |
| Eisai INC. | $294.82 | 2019-2021 | |
| Biogen, INC. | $157.65 | 2019-2021 | |
| Greenwich Biosciences, INC. | $156.92 | 2019 | |
| Travere Therapeutics, INC. | $113.53 | 2019-2021 | |
| Livanova USA, INC. | $107.74 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Neuropace, INC. | $77.68 | 2024 | |
| Sumitomo Pharma America, INC. | $58.50 | 2023 | Aptiom |
| Neurelis, INC. | $37.66 | 2020-2024 | Valtoco |
| Neurocrine Biosciences, INC. | $37.18 | 2024 | Ingrezza |
| Biomarin Pharmaceutical INC. | $35.08 | 2019 | |
| Mallinckrodt Enterprises LLC | $34.28 | 2019 | |
| Abbvie INC. | $33.42 | 2024 | |
| Revance Therapeutics, INC. | $27.75 | 2024 | Daxxify |
| Supernus Pharmaceuticals, INC. | $25.90 | 2019-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aquestive Therapeutics, INC. | $20.90 | 2019 | |
| Lilly USA, LLC | $19.71 | 2025 | Kisunla |
| Sk Life Science, INC. | $18.79 | 2021 | |
| Ge Healthcare | $17.94 | 2020 | |
| Jazz Pharmaceuticals INC. | $17.34 | 2024 | |
| Ptc Therapeutics, INC. | $16.79 | 2019 | |
| Acadia Pharmaceuticals INC | $16.31 | 2023 | Nuplazid |
| Medtronic USA, INC. | $14.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Chacon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.